K5N (p.Lys5Asn) variant of KRAS (GTPase KRas)
K5N (p.Lys5Asn) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of RASopathy. The available variant effect predictions contribute to a CATVariant prioritization score of 1.00 / 1. The record also includes experimental measurements, published literature, and structural context.
K5N (p.Lys5Asn) variant details
- p.Lys5Asn
- rs104894361
- ClinGen CA16042877
- cosmic curated COSV56027
- ClinVar RCV000413067
- Pathogenic
- RASopathy
- Missense
- Variant Prioritization Score for Impact Estimate 0.996
- ESM-1b 1.00
- AlphaMissense 0.99
- ClinVar: Pathogenic (not provided)
- EBI: Pathogenic (in GASC)
- UniProt: Pathogenic (in GASC)
- Structural context available
- KRAS activity — DMSO (standardized): score 7.12
- Cited in: BRAF and KRAS mutations in stomach cancer. (PMID 14534542)
- Cited in: Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. (PMID 17056636)